Saudi Pharmaceutical Industries & Medical Appliances Corp.’s (SPIMACO) board of directors has approved the establishment of a new SAR 100 million specializing in quasi-pharmaceutical and medical cosmetics, the company said in a statement to Tadawul.
The new entity will be constructed on a 95,000 square meter land plot in Al Qassim, the statement added.
The total cost of the project is estimated at SAR 200 million. The amount will be financed through the company’s resources, as well as bank loans.
The launch is part of SPIMACO’s strategy to maintain its market share and meet growing demand for medical cosmetic products in Saudi Arabia and the wider Middle East region.
SPIMACO will own 65 percent of the new entity, while its 95-percent owned subsidiary ARAC Health Care, will take a 15 percent position.
The Jordan-based Arab Company for Drug Industries and Medical Appliances (ACDIMA), which owns 20.48 percent of SPIMACO, will hold a 20 percent stake in the new company.